Hypnotherapy for Oral Lichen Planus. Patients with Clinically and Histologically Confirmed Oral Lichen Planus Would Be Randomized for Hypnotherapy Vs Psychoeducation About the Pyschoneuroimmune System. Follow Up Would Be Done At 2, 6, 12 Weeks After.
Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Nov 19, 2024
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background:
Lichen planus (LP) is an immune-mediated skin and mucous membrane disease that mainly affects middle-aged adults of both sexes with a slight tendency to women. The precise prevalence of LP is unknown, but it is estimated that the oral form (OLP) alone is expressed in about 1-2% of the population. OLP is a chronic disease and it is considered by the World Health Organization (WHO) as a pre-malignant condition. OLP presents in five clinical forms - reticular, plaque-like, erythematous/atrophic, erosive/ulcerative and bullous. The reticular form is the most common and is character...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Histopathologically and clinically confirmed diagnosis of OLP.
- • At least 1 year since diagnosis.
- • Above 18 years of age.
- • Fluent in Hebrew or English (for the purpose of hypnosis).
- • Lesions that are consistent with OLP are clinically visible in oral cavity.
- Exclusion Criteria:
- • Under aged.
- • Previous negative experience with hypnosis.
- • Psychiatric diagnosis of schizophrenia, personality disorder, severe depression, or history of psychosis.
- • Substantial cognitive decline.
- • Low hypnotisability.
- • Previous oral squamous cell carcinoma.
About Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported